Leaderboard

En | De
Sie sind hier: Gastroenterologie » Pankreas » Neoplasie 27. Februar 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2961  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 59203  
   
MOLECULAR ALTERATIONS OF MUC1 AND THEIR THERAPEUTIC EXPLOITATION: EMERGING OPPORTUNITIES IN CANCER THERAPY.
Crit Rev Oncol Hematol
Khan MS, Almalki WH.
PMID: 41747815 [PubMed - as supplied by publisher]


Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results From the Phase 2 LEAP-005 Study.
Cancer Res Commun
Ponz-Sarvisé M, Rha SY, Gomez-Roca CA, Ortega Morán L, Gill S, Tortora G, Geva R, Saada-Bouzid E, Santoro A, Kim TW, Heudobler D, Dutcus CE, Okpara CE, Ghori R, Zhang Y, Vajdi A, Dettman EJ, Jin F, Groisberg R, Shapira-Frommer R.
PMID: 41747221 [PubMed - as supplied by publisher]


Evaluating deep learning models for pancreatic cancer diagnosis.
Clin Exp Med
Li D, He H, Hu J, Ding Y, Kong L, Hu A.
PMID: 41746513 [PubMed - as supplied by publisher]


Exploratory Analysis of Gut Microbiome and Metabolic Profile Changes Following Lenvatinib and Anti-PD-1 Combination Therapy in Liver Cancer.
Metabolites
Zhong R, Lin Z, Jin B, Wang X, Mu H, Hu J, Li Q, Dou P, Liu X, Hu C, Xu G, Tan G.
PMID: 41745580 [PubMed]


Preclinical exploration and current clinical applications of immunotherapeutic strategies for hepatocellular carcinoma.
Front Immunol
Yu H, Wen X, Cui M, Liu S.
PMID: 41743701 [PubMed - in process]


Reassessing cancer risk with GLP-1 receptor agonists: a comprehensive meta-analysis of gastrointestinal malignancies.
Front Pharmacol
Wali AF, Rangraze I, Khan S, Mufti UB, El-Tanani M, Rizzo M.
PMID: 41743116 [PubMed]


STOML2 promotes hepatocellular carcinoma cell proliferation, invasion and migration by activating the PI3K/AKT signaling pathway (Review).
Oncol Lett
Li M, Chen J.
PMID: 41743019 [PubMed]


Atezolizumab and Motixafortide, Cobimetinib or Simlukafusp Alfa in Pretreated Advanced Pancreatic Cancer: Phase I/IIb MORPHEUS-PDAC Umbrella Study.
Oncologist
Manji GA, Chung V, Oh DY, Lacy J, Lopez CD, Ponz-Sarvisé M, Macarulla T, Thomas R, George B, Alistar A, Siveke JT, Xu Y, Lau J, Cha E, Kim KP, O'Reilly EM.
PMID: 41741368 [PubMed - as supplied by publisher]


Ultrasound-driven sonodynamic therapy for hepatocellular carcinoma.
Chem Commun (Camb)
Chen W, Dong L, Xiao X.
PMID: 41739066 [PubMed - as supplied by publisher]


Associations between parenteral energy or amino acid doses and clinical outcomes in fasting patients undergoing gastroenterological cancer surgery: a nationwide cohort study using real-world data.
Gastroenterol Rep (Oxf)
Kawaguchi Y, Murotani K, Hayashi N, Kamoshita S.
PMID: 41737807 [PubMed]


Analyses of the Coexpression of Lactate Metabolism- and Ferroptosis-Related Genes in Hepatocellular Carcinoma.
J Hepatocell Carcinoma
Wu K, Qiao C, Gao C, Chen T, Pei S, Wang S, Yu D.
PMID: 41737777 [PubMed]


Exploration of multi-omics liquid biopsy approaches for multi-cancer early detection: The PROMISE study.
Innovation (Camb)
Duan J, Gao Q, Wang Z, Xu J, Zhang Y, Wang Y, Yang X, Zhang L, Xu Y, Zhou Q, Yang B, Yang X, Wang G, Zhao J, Wang X, Ge D, Tan L, Chang W, Xu J, Zhou P, He M, Song Y, Hu J, Lou W, Wu W, Shi T, Zang R, Ji Y, Jiang S, Lin Y, Dong L, Cai S, Fan J, Wang J.
PMID: 41737326 [PubMed]


Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized controlled trial.
BMC Cancer
Jung HS, Choi J, Park SJ, Han Y, Cho YJ, Yoon J, Oh DY, Yoon YS, Kim JW, Lim CS, Park JH, Choi IS, Hong TH, Kim HS, Jeung HC, Ahn KS, Kim JY, Yu YD, Kim JW, Hwang HK, Lee CK, Choi HJ, Jung YK, Park K, Yoon JH, Han IW, Hong JY, Seo HI, Do Yang J, Jeon SY, Yang SJ, Chon HJ, Kwon W, Park JS, Shan YS, Lee MA, Jang JY.
PMID: 41735896 [PubMed - as supplied by publisher]


Clinicopathologic characteristics, progression, and prognostic analysis of intraductal papillary neoplasm of the bile duct: a retrospective multicenter cohort study.
Int J Surg
Zhao ZH, Zhang R, Zhang A, Yao XX, Ma L, Shi J, Bi J, Zhang HT, Zhang R, Feng Q, Lv G, Wang M.
PMID: 41731872 [PubMed - indexed for MEDLINE]


The role of surgical resection, locoregional liver-directed treatments, and continuous systemic treatment in patients with liver metastatic pancreatic cancers.
Int J Surg
Li X, Qiao G, Chen Y, Gao F, Zhang X, Xiao W, Sun K, Sun X, Bai X, Liang T.
PMID: 41731869 [PubMed - indexed for MEDLINE]


Predictive model and novel classification of pancreatic fistula following minimally invasive enucleation: a prospective cohort study (CSPAC-MIEN-2).
Int J Surg
Wang T, Li Z, Shi Y, Dang Q, Wu J, Liu M, Chen H, Chen C, Xu W, Liu W, Zhou C, Zhuo Q, Ji S, Wang L, Qin Y, Yu X, Xu X.
PMID: 41731864 [PubMed - indexed for MEDLINE]


Exploring dietary habits strongly associated with pancreatic cancer from the perspective of Mendelian randomization.
Medicine (Baltimore)
Chen S, Liu Y, Fan T, Yuan H, Guo T, Wang J.
PMID: 41731762 [PubMed - indexed for MEDLINE]


EPI-X4 is a peptide antagonist of CXCR4 with therapeutic prospects for cancer and inflammatory disorders.
Peptides
Sagini MN, Berger MR, Muthmann J, Alt E, Forssmann WG.
PMID: 41730454 [PubMed - as supplied by publisher]


Stereotactic Adaptive Radiation Therapy for Borderline Resectable or Locally Advanced Pancreatic Cancer to Minimize Gastrointestinal Toxicity (ARTIA-Pancreas): Protocol for a Single-Arm Prospective Trial.
JMIR Res Protoc
Henke LE, Kim H, Laugeman E, Kohlmyer S, McCann C, Pietrovito K, Russell K, Woo J, Price AT.
PMID: 41730182 [PubMed - indexed for MEDLINE]


AI-Driven Patient Screening for Clinical Trials in Pancreatic Cancer: The PANCR-AI Pilot Retrospective Comparative Study.
JMIR Cancer
Claessens A, Simon A, Manchart A, Desmonts L, Leguay C, Faivre JC, Cambier S, Salleron J, Lambert A.
PMID: 41730173 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 59203    Seite 1 von 2961  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1